Penny Pinnock, sales manager – Healthcare & Public Sector for Siemens Financial Services (SFS) discusses why NHS trusts must work together to meet the challenges facing their laboratories.
EPM speaks to Paul Burden, chief commercial officer – Strategic Growth, at ADVANZ PHARMA about niche medicines, the challenges of working with multiple partners and why competition is everywhere in pharma.
EPM speaks to Jean-Pierre Joubert, product manager at CN Bio Innovations who talks about his journey into biotech, the challenges of drug development, and why opportunities come from unlikely places.
Noel Maestre, advanced therapy medicinal product (ATMP) director at CRB guides readers through the steps needed to implement manufacturing strategies for advanced medicines.
EPM speaks to Neil Tween, CFO at Owlstone Medical, who tells us why diagnostics still have a vital role to play in healthcare and the lessons he's learned from working in the industry.
With the high costs of drug discovery, Tyler Golato, scientific lead at Molecule, discusses why new business models are needed if innovation is to continue.
The Centre for Process Innovation has announced a collaboration with major pharma players GSK and AstraZeneca to create a continuous wet granulation manufacturing facility for oral solid dosage pharmaceuticals.
